Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$100.67 USD

100.67
1,193,040

+1.75 (1.77%)

Updated Aug 9, 2024 04:00 PM ET

After-Market: $100.67 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 20% (200 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Seeking Clues to Cardinal (CAH) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

The Joint (JYNT) delivered earnings and revenue surprises of -500% and 2.06%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know

by Zacks Equity Research

Cardinal Health (CAH) closed at $99.52 in the latest trading session, marking a +1.18% move from the prior day.

Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 4.55% and 0.92%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) Rises But Trails Market: What Investors Should Know

by Zacks Equity Research

Cardinal Health (CAH) reachead $100.83 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cardinal Health (CAH) Rises As Market Takes a Dip: Key Facts

by Zacks Equity Research

In the most recent trading session, Cardinal Health (CAH) closed at $96.71, indicating a +0.91% shift from the previous trading day.

Why the Market Dipped But Cardinal Health (CAH) Gained Today

by Zacks Equity Research

In the closing of the recent trading day, Cardinal Health (CAH) stood at $95.84, denoting a +0.44% change from the preceding trading day.

Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings

by Zacks Equity Research

FDA investigations into Cardinal Health's (CAH) China-based syringe manufacturers, Jiangsu Shenli and Jiangsu Caina, reveal significant quality violations, prompting recalls and import alerts.

Why the Market Dipped But Cardinal Health (CAH) Gained Today

by Zacks Equity Research

Cardinal Health (CAH) closed at $95.97 in the latest trading session, marking a +0.59% move from the prior day.

Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why

by Zacks Equity Research

Cardinal Health (CAH) concluded the recent trading session at $93.74, signifying a -0.38% move from its prior day's close.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now

by Zacks Equity Research

Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors

by Zacks Equity Research

Cardinal Health (CAH) concluded the recent trading session at $96.01, signifying a -0.9% move from its prior day's close.

Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes

by Zacks Equity Research

Cardinal Health (CAH) recalls its procedure kits that contain plastic syringes manufactured by a Chinese manufacturer, Jiangsu Shenli.

Cencora (COR) Stock Nosedives: Here's What Caused the Decline

by Zacks Equity Research

Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court related to a previously settled litigation. Here we discuss the key factors that likely led to the decline.

Cardinal Health (CAH) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the closing of the recent trading day, Cardinal Health (CAH) stood at $101.10, denoting a -1.97% change from the preceding trading day.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Cardinal Health (CAH) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now

by Zacks Equity Research

Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising cost of products is a concern.

Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?

by Zacks Equity Research

Tandem Diabetes (TNDM) outperforms the industry, owing to its impressive series of product launches and an impressive quarterly performance.

Investors Heavily Search Cardinal Health, Inc. (CAH): Here is What You Need to Know

by Zacks Equity Research

Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is What to Know Beyond Why Cardinal Health, Inc. (CAH) is a Trending Stock

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.